Meetings & Events

Evaluation and Management of Early Menopause

July 21, 2020

Session Description: This session will include case-based discussions of the evaluation for genetic causes of premature menopause (e.g., Turner and Fragile X syndromes), the hormonal management of early menopause and preventive therapies for potential adverse effects including osteoporosis and cardiovascular disease.

Faculty: Kathryn Martin, MD
Massachusetts General Hospital

Learning Objectives:

After this session, attendees will be able to:

  1. Describe the diagnostic evaluation of premature menopause (onset ≤ 45 years old) and primary ovarian insufficiency.
  2. Identify the best hormonal therapy regimens for women with early menopause and primary ovarian insufficiency.
  3. Describe the non-hormonal and hormonal management of the health risks of premature menopause (onset ≤ 45 years old) and primary ovarian insufficiency (including reduced fertility).

Return to the full CEU program.

Last Updated:
Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!